Upon initiation of a GLP-1 RAs and during up-titration, it is advisable for cardiologists to counsel their patients to take smaller meals, eat slowly and stop before feeling full, and avoid fatty or spicy foods ( 4 Conclusion GLP-1 RAs seem to emulate the evolution of statins and sodium-glucose co-transporter-2 inhibitors in terms of being approved for indications other than their initial indication and becoming promising agents in CV medicine which will continue to grow
Official guidance from UK health authorities The National Institute for Health and Care Excellence (NICE) recommends GLP-1 drugs for patients with type 2 diabetes or with a very high BMI 12
Role in GLOW GHK-Cu addresses both sides of skin remodeling: removing damaged matrix and building its replacement
The GLP-1R agonists are promising candidates for the treatment of obesity
They are suitable for the treatment of: Fatigue and lethargy, dementia, stress- related disorders including anxiety, panic disorders, high blood pressures, weight loss & mental clarity
Reward milestones with non-food treats like new workout gear or a massage